Xeris Drug Patent Portfolio
Xeris owns 3 orange book drugs protected by 2 US patents Given below is the list of Xeris's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11590205 | Methods for producing stable therapeutic glucagon formulations in aprotic polar solvents | 22 Apr, 2036 | Active |
| US9649364 | Methods for producing stable therapeutic formulations in aprotic polar solvents | 22 Apr, 2036 | Active |
Latest Legal Activities on Xeris's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Xeris.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
|
Email Notification
Critical
| 28 Feb, 2023 | US11590205 |
|
Email Notification
Critical
| 28 Feb, 2023 | US11590205 |
|
Email Notification
Critical
| 28 Feb, 2023 | US11590205 |
|
Recordation of Patent Grant Mailed
Critical
| 28 Feb, 2023 | US11590205 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 28 Feb, 2023 | US11590205 |
|
Recordation of Patent Grant Mailed
Critical
| 28 Feb, 2023 | US11590205 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 28 Feb, 2023 | US11590205 |
|
Recordation of Patent Grant Mailed
Critical
| 28 Feb, 2023 | US11590205 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 28 Feb, 2023 | US11590205 |
|
Issue Notification Mailed
Critical
| 08 Feb, 2023 | US11590205 |
|
Issue Notification Mailed
Critical
| 08 Feb, 2023 | US11590205 |
|
Issue Notification Mailed
Critical
| 08 Feb, 2023 | US11590205 |
|
Application Is Considered Ready for Issue
Critical
| 24 Jan, 2023 | US11590205 |
|
Application Is Considered Ready for Issue
Critical
| 24 Jan, 2023 | US11590205 |
| Dispatch to FDC | 24 Jan, 2023 | US11590205 |
Xeris's Family Patents
Xeris Drug List
Given below is the complete list of Xeris's drugs and the patents protecting them.
1. Gvoke Hypopen
Gvoke Hypopen is protected by 2 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11590205 | Methods for producing stable therapeutic glucagon formulations in aprotic polar solvents |
22 Apr, 2036
(11 years from now)
| Active |
| US9649364 | Methods for producing stable therapeutic formulations in aprotic polar solvents |
22 Apr, 2036
(11 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Gvoke Hypopen's drug page
2. Gvoke Kit
Gvoke Kit is protected by 1 patent, which is still active. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11590205 | Methods for producing stable therapeutic glucagon formulations in aprotic polar solvents |
22 Apr, 2036
(11 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Gvoke Kit's drug page
3. Gvoke Pfs
Gvoke Pfs is protected by 2 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11590205 | Methods for producing stable therapeutic glucagon formulations in aprotic polar solvents |
22 Apr, 2036
(11 years from now)
| Active |
| US9649364 | Methods for producing stable therapeutic formulations in aprotic polar solvents |
22 Apr, 2036
(11 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Gvoke Pfs's drug page